ANTI MULLERIAN HORMONE (AMH) ULTRASENSITIVE; MENOCHECK

MENOCHECK IS THE FIRST EVER FDA CLEARED AMH BLOOD TEST THAT HELPS TO DETERMINE TIME TO FINAL MENSTRUAL PERIOD (FMP) IN A WOMAN. MENOPAUSAL TRANSITION IS HIGHLY VARIABLE AMONG WOMEN. IRREGULAR MENSTRUAL PATTERN AND VASOMOTOR SYMPTOMS DURING THIS TRANSITION CAN DISRUPT THE QUALITY OF LIFE BY CAUSING HOT FLASHES, MOOD CHANGES, NIGHT SWEATING, SLEEP DISTURBANCES ETC. EARLY OR PREMATURE MENOPAUSE ALSO INCREASES THE RISK OF OSTEOPOROSIS AND CARDIOVASCULAR DISEASES. THEREFORE, KNOWING THE MENOPAUSAL STATUS AND APPROXIMATELY HOW LONG SHE PERSONALLY WILL HAVE TO ENDURE SYMPTOMS CAN HELP DISCUSSION WITH CLINICIAN AND PERSONALIZE DECISION FOR PREVENTIVE CARE. ALSO, ESTIMATING TIME TO FMP CAN HELP WOMEN TO DECIDE WHEN CONTRACEPTION IS NO LONGER NEEDED.